Biora Therapeutics to Participate in Upcoming H.C. Wainwright Global Investment Conference
Biora Therapeutics (Nasdaq: BIOR) announced its participation in the H.C.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Biora Therapeutics (Nasdaq: BIOR) announced its participation in the H.C. Wainwright Global Investment Conference from May 23 to 26, 2022, at the Fontainebleau Hotel in Miami, Florida. The management team will give a corporate overview and hold one-on-one meetings with attendees. The presentation is scheduled for May 24, from 3:00 PM to 4:00 PM Eastern Time. Interested individuals can access the webcast through Biora's website, with replays available for 60 days. Biora is focused on innovative therapeutics, including smart pills for targeted drug delivery.
Details
News Market Reaction – BIOR
The recorded move for BIOR in the trading session of this news was +8.96%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today announced that the Company’s management team will be presenting a corporate overview and participating in one-on-one meetings, upon request, with conference attendees at the upcoming H.C. Wainwright Global Investment Conference, which is taking place both virtually and in-person at the Fontainebleau Hotel in Miami, Florida, May 23 to 26, 2022.
H.C. Wainwright Global Investment Conference
Date: Tuesday, May 24, 2022
Time: 3:00 PM to 4:00 PM Eastern Time
A link to join the webcast is available at bioratherapeutics.com/presentations and a replay will be available for 60 days following the conference.
About Biora Therapeutics
Biora Therapeutics is the biotech company that is reimagining therapeutics. By creating innovative smart pills designed for targeted drug delivery to the GI tract, and systemic, needle-free delivery of biotherapeutics, the company is developing therapies to improve patients’ lives. Biora envisions a world where patients have access to needle-free drug delivery and better therapeutic outcomes.
For more information, visit bioratherapeutics.com or follow the company on LinkedIn or Twitter.
Investor Contact
Chuck Padala
Managing Director, LifeSci Advisors
IR@bioratherapeutics.com
(646) 627-8390
Media Contact
media@bioratherapeutics.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.